General Information

Mail: University of Houston
Cullen College of Engineering
E421 Engineering Bldg 2, Houston, TX 77204-4007
Map & Driving Directions (includes parking information)
Email: info [at] egr [dot] uh [dot] edu

News

ChBE PhD Candidate Wins Three AIChE Awards

Printer-friendly versionSend by emailPDF version

By: 

Esmeralda Fisher
Alexandra Lupulescu, winner of the 2012 AIChE CRE Division Poster Competition.
Alexandra Lupulescu, winner of the 2012 AIChE CRE Division Poster Competition.

Alexandra Lupulescu, a Ph.D. candidate in the University of Houston Department of Chemical and Biomolecular Engineering, was selected as the winner of the Catalysis and Reaction Engineering Division Poster Competition held during the 2012 American Institute of Chemical Engineers (AIChE) Annual Meeting in Pittsburgh, for her poster titled “Employing Molecular Modifiers to Tailor the Crystal Morphology of Zeolite Catalysts.”

As part of assistant professor Jeffrey Rimer’s research team, Lupulescu focuses on optimizing zeolites, a type of catalyst. Zeolites are crystalline materials that contain silica and alumina, which are used in a variety of chemical processes. She is working to modify the overall shape of zeolites for better performance in environmentally-friendly applications.

Lupulescu was also the 2nd place winner of the 2012 AIChE Environmental Division's graduate student award, for a paper co-authored with Rimer titled "Tailoring Silicalite-1 Crystal Morphology with Molecular Modifiers" published in Angewandte Chemie International Edition.

She was also selected by the CRE Division Travel Awards Committee to receive an award for travel to the AIChE Annual Meeting.

Lupulescu completed her undergraduate degree in chemical engineering from Tulane University. 

Faculty: 

Department: 

Related News Stories

Researcher Publishes Paper on Engineered Antibody that Targets Acute Myeloid Leukemia

Almost 19,000 new cases of acute myeloid leukemia and 10,500 deaths from the blood and bone marrow cancer could strike Americans this year, according to the American Cancer Society. Chemotherapy, when used as primary treatment, is successful in about 65 percent of patients with the cancer, and remission rates vary depending on patients’ individual characteristics, according to the organization.

Upcoming Events / Seminars

Archived News